Journey Medical Corporation (NASDAQ:DERM) Surges 55% Yet Its Low P/S Is No Reason For Excitement

The Journey Medical Corporation (NASDAQ:DERM) share price has done very well over the last month, posting an excellent gain of 55%. The last month tops off a massive increase of 146% in the last ye

Simply Wall StJun 15 08:13 ET

Public Companies Are Journey Medical Corporation's (NASDAQ:DERM) Biggest Owners and Were Rewarded After Market Cap Rose by US$26m Last Week

Yahoo FinanceJun 11 06:39 ET

Why Skye Bioscience Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Shares of Skye Bioscience, Inc. (NASDAQ:SKYE) fell sharply during Monday's session after the company announced its SBI-100 Ophthalmic Emulsion Phase 2a trial did not achieve target product profile and

BenzingaJun 10 14:10 ET

Journey Medical Corporation to Participate in the Alliance Global Partners' (A.G.P.) Virtual Healthcare Company Showcase

SCOTTSDALE, Ariz., May 15, 2024 (GLOBE NEWSWIRE) -- Journey Medical Corporation ("Journey Medical" or "the Company") (NASDAQ:DERM), a commercial-stage pharmaceutical company that primarily focuses on the selling and

GlobeNewswireMay 15 16:01 ET

Journey Medical | 10-Q: Quarterly report

SEC announcementMay 14 16:52 ET · Announcements

Earnings Call Summary | Journey Medical(DERM.US) Q1 2024 Earnings Conference

The following is a summary of the Journey Medical Corporation (DERM) Q1 2024 Earnings Call Transcript:Financial Performance:Journey Medical reported Q1 revenue of $13 million, a 7% increase year-over-

moomoo AIMay 14 04:56 ET · Conference Call